Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bitcoin Price Stabilizes Amid Strategy $8 Billion Loss

Bitcoin Price Stabilizes Amid Strategy $8 Billion Loss

CoinspeakerCoinspeaker2026/08/02 12:42
By:Coinspeaker

The Bitcoin price (BTC USD) is trading at $63,900, up a modest +0.4% over 24 hours, as the market digests a sobering second-quarter earnings report from Strategy, the company that built its entire identity around institutional BTC accumulation.

The firm swung from a $10Bn profit in Q2 2025 to an $8.2Bn loss this quarter, driven almost entirely by unrealized losses on its bitcoin holdings. What happens next to the spot price depends on a support cluster that is thinner than it looks.

Strategy disclosed in its Q2 2026 earnings that bitcoin’s spot price finished the quarter more than 40% lower year-over-year, according to the company’s own filing. The firm grew its BTC stack by 11% during the quarter, reaching a peak of 846,000 BTC before beginning selective asset sales.

As of its most recent 8-K, Strategy holds 843,775 BTC. CEO Phong Le noted the firm reduced convertible debt by 18% to $6.7Bn and grew its USD reserve by 12% to $2.4Bn, a deliberate pivot toward balance-sheet defensibility over accumulation. Strategy has now paused BTC purchases for five consecutive weeks, a streak that has measurably removed one of the market’s most visible demand signals.

Can the Bitcoin Price Recover to $70,000 Before Quarter-End?

At $64,000, Bitcoin is trading inside a contested range with its daily session low at $63,986 and the intraday high reaching $65,372, a relatively tight band that reflects consolidation rather than conviction.

The first meaningful support sits at $60,000, a level that Mudrex analyst Akshat Siddhant identifies as the critical floor, below which a demand zone opens between $57,500 and $55,000. A prior session low near $59,100 already tested market resolve once; holding above it matters.

On the resistance side, immediate overhead supply is clustered at $64,500–$65,000, a range Bitcoin is currently pressing against without a clean break. A sustained close above that band is a prerequisite for any credible recovery narrative. Beyond that, $71,000–$72,000 represents the top of the broader consolidation range.

This is a level that would signal structural improvement rather than a dead-cat bounce. Bitcoin is currently trading below key moving averages, and a joint Coinbase Institutional–Glassnode report argues that post-Q4 deleveraging has shifted Bitcoin into a more macro-driven, less liquidation-prone phase, which cuts both ways.

Three scenarios worth tracking:

Bull case: The Bitcoin price holds $60,000, closes above $65,000, and retests $71,000 on improved ETF (exchange-traded fund) inflows.

Base case: consolidation between $62,000 and $65,000 continues for another two to three weeks as macro data and Fed commentary provide direction.

Bear/invalidation: a close below $59,100 opens the $57,500 zone and resets the recovery thesis entirely. The RSI recovering from an extreme oversold reading near 15.5 does historically precede sizable rebounds of 30–50%, but history rhymes; it does not repeat on schedule.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification

Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.

智通财经2026/09/21 11:06

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

智通财经2026/09/21 09:31
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

STONK hits new highs after erasing 27% crash

Cryptopolitan2026/09/21 09:30
STONK hits new highs after erasing 27% crash